Cargando…

30-day outcomes in hip fracture patients during the COVID-19 pandemic compared to the preceding year

AIMS: To establish if COVID-19 has worsened outcomes in patients with AO 31 A or B type hip fractures. METHODS: Retrospective analysis of prospectively collected data was performed for a five-week period from 20 March 2020 and the same time period in 2019. The primary outcome was mortality at 30 day...

Descripción completa

Detalles Bibliográficos
Autores principales: Macey, Alistair R. M., Butler, Joanna, Martin, Sean C., Tan, Ting Yang, Leach, William J., Jamal, Bilal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone and Joint Surgery 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659666/
https://www.ncbi.nlm.nih.gov/pubmed/33215132
http://dx.doi.org/10.1302/2633-1462.17.BJO-2020-0077.R1
_version_ 1783608857496387584
author Macey, Alistair R. M.
Butler, Joanna
Martin, Sean C.
Tan, Ting Yang
Leach, William J.
Jamal, Bilal
author_facet Macey, Alistair R. M.
Butler, Joanna
Martin, Sean C.
Tan, Ting Yang
Leach, William J.
Jamal, Bilal
author_sort Macey, Alistair R. M.
collection PubMed
description AIMS: To establish if COVID-19 has worsened outcomes in patients with AO 31 A or B type hip fractures. METHODS: Retrospective analysis of prospectively collected data was performed for a five-week period from 20 March 2020 and the same time period in 2019. The primary outcome was mortality at 30 days. Secondary outcomes were COVID-19 infection, perioperative pulmonary complications, time to theatre, type of anaesthesia, operation, grade of surgeon, fracture type, postoperative intensive care admission, venous thromboembolism, dislocation, infection rates, and length of stay. RESULTS: In all, 76 patients with hip fractures were identified in each group. All patients had 30-day follow-up. There was no difference in age, sex, American Society of Anesthesiologists (ASA) classification or residence at time of injury. However, three in each group were not fit for surgery. No significant difference was found in 30-day mortality; ten patients (13%) in 2019 and 11 patients (14%) in 2020 (p = 0.341). In the 2020 cohort, ten patients tested positive for COVID-19, two (20%) of whom died. There was no significant increase in postoperative pulmonary complications. Median time to theatre was 20 hours (interquartile range (IQR) 16 to 25) in 2019 versus 23 hours (IQR 18 to 30) in 2020 (p = 0.130). Regional anaesthesia increased from 24 (33%) cases in 2019 to 46 (63%) cases in 2020, but ten (14%) required conversion to general anaesthesia. In both groups, 53 (70%) operations were done by trainees. Hemiarthroplasty for 31 B type fractures was the most common operation. No significant difference was found for intensive care admission or 30-day venous thromboembolism, dislocation or infection, or length of stay. CONCLUSION: Little information exists on mortality and complications after hip fracture during the COVID-19 pandemic. At the time of writing, no other study of outcomes in the UK has been published. Cite this article: Bone Joint Open 2020;1-7:415–419.
format Online
Article
Text
id pubmed-7659666
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The British Editorial Society of Bone and Joint Surgery
record_format MEDLINE/PubMed
spelling pubmed-76596662020-11-18 30-day outcomes in hip fracture patients during the COVID-19 pandemic compared to the preceding year Macey, Alistair R. M. Butler, Joanna Martin, Sean C. Tan, Ting Yang Leach, William J. Jamal, Bilal Bone Jt Open General Orthopaedics AIMS: To establish if COVID-19 has worsened outcomes in patients with AO 31 A or B type hip fractures. METHODS: Retrospective analysis of prospectively collected data was performed for a five-week period from 20 March 2020 and the same time period in 2019. The primary outcome was mortality at 30 days. Secondary outcomes were COVID-19 infection, perioperative pulmonary complications, time to theatre, type of anaesthesia, operation, grade of surgeon, fracture type, postoperative intensive care admission, venous thromboembolism, dislocation, infection rates, and length of stay. RESULTS: In all, 76 patients with hip fractures were identified in each group. All patients had 30-day follow-up. There was no difference in age, sex, American Society of Anesthesiologists (ASA) classification or residence at time of injury. However, three in each group were not fit for surgery. No significant difference was found in 30-day mortality; ten patients (13%) in 2019 and 11 patients (14%) in 2020 (p = 0.341). In the 2020 cohort, ten patients tested positive for COVID-19, two (20%) of whom died. There was no significant increase in postoperative pulmonary complications. Median time to theatre was 20 hours (interquartile range (IQR) 16 to 25) in 2019 versus 23 hours (IQR 18 to 30) in 2020 (p = 0.130). Regional anaesthesia increased from 24 (33%) cases in 2019 to 46 (63%) cases in 2020, but ten (14%) required conversion to general anaesthesia. In both groups, 53 (70%) operations were done by trainees. Hemiarthroplasty for 31 B type fractures was the most common operation. No significant difference was found for intensive care admission or 30-day venous thromboembolism, dislocation or infection, or length of stay. CONCLUSION: Little information exists on mortality and complications after hip fracture during the COVID-19 pandemic. At the time of writing, no other study of outcomes in the UK has been published. Cite this article: Bone Joint Open 2020;1-7:415–419. The British Editorial Society of Bone and Joint Surgery 2020-11-02 /pmc/articles/PMC7659666/ /pubmed/33215132 http://dx.doi.org/10.1302/2633-1462.17.BJO-2020-0077.R1 Text en © 2020 Author(s) et al. https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This is an open-access article distributed under the terms of the Creative Commons Attributions licence (CC-BY-NC-ND), which permits unrestricted use, distribution, and reproduction in any medium, but not for commercial gain, provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle General Orthopaedics
Macey, Alistair R. M.
Butler, Joanna
Martin, Sean C.
Tan, Ting Yang
Leach, William J.
Jamal, Bilal
30-day outcomes in hip fracture patients during the COVID-19 pandemic compared to the preceding year
title 30-day outcomes in hip fracture patients during the COVID-19 pandemic compared to the preceding year
title_full 30-day outcomes in hip fracture patients during the COVID-19 pandemic compared to the preceding year
title_fullStr 30-day outcomes in hip fracture patients during the COVID-19 pandemic compared to the preceding year
title_full_unstemmed 30-day outcomes in hip fracture patients during the COVID-19 pandemic compared to the preceding year
title_short 30-day outcomes in hip fracture patients during the COVID-19 pandemic compared to the preceding year
title_sort 30-day outcomes in hip fracture patients during the covid-19 pandemic compared to the preceding year
topic General Orthopaedics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659666/
https://www.ncbi.nlm.nih.gov/pubmed/33215132
http://dx.doi.org/10.1302/2633-1462.17.BJO-2020-0077.R1
work_keys_str_mv AT maceyalistairrm 30dayoutcomesinhipfracturepatientsduringthecovid19pandemiccomparedtotheprecedingyear
AT butlerjoanna 30dayoutcomesinhipfracturepatientsduringthecovid19pandemiccomparedtotheprecedingyear
AT martinseanc 30dayoutcomesinhipfracturepatientsduringthecovid19pandemiccomparedtotheprecedingyear
AT tantingyang 30dayoutcomesinhipfracturepatientsduringthecovid19pandemiccomparedtotheprecedingyear
AT leachwilliamj 30dayoutcomesinhipfracturepatientsduringthecovid19pandemiccomparedtotheprecedingyear
AT jamalbilal 30dayoutcomesinhipfracturepatientsduringthecovid19pandemiccomparedtotheprecedingyear